Bluestone Trials

Psoriasis Study

Do you have Psoriasis?
Status: Completed.

We are conducting a clinical trial for an investigational medication for the treatment of moderate to severe psoriasis.

The purpose of this study is to determine the safety of novel treatment and to learn about how it interacts with the body in people with moderate to severe psoriasis. The study drug will be given to people with psoriasis for the first time in this study.


This study consists of approximately 19 visits at our study site, over a 22-week period. Qualifying participants can be compensated for time and travel expenses.

If you are at least 18 years of age or older and suffer with moderate to severe psoriasis, you may be eligible to participate in this research study.

Study Background:

Psoriasis is a non contagious, lifelong skin disease characterized by raised, inflamed, red patches covered by a silvery white buildup of dead skin cells called scale. These patches are typically found on the elbows, knees, scalp, and lower back.  According to the National Institutes of Health, as many as 7.5 million Americans have psoriasis. About 10 percent to 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. There is currently no permanent cure for psoriasis. The treatments available today help to decrease any discomfort from the disease.